On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy project for a study in mice the influence of host genetics on response to immunotherapy.

The goal of this project was to generate insights that will empower future decisions about the best treatments for cancer patients based on their genetic backgrounds.